{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:26Z","timestamp":1790742506500,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bpobgyn.2023.102340","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T12:26:04Z","timestamp":1681820764000},"page":"102340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The value of treatment for infertility: A systematic literature review of willingness-to-pay thresholds and approaches for determining the cost effectiveness of fertility therapies"],"prefix":"10.1016","volume":"89","author":[{"given":"Elisabeth","family":"Fenwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaeze","family":"Eze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D'Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek S.","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ostawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Harty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2023.102340_bib1","series-title":"Infertility: key facts","year":"2020"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102340_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/humupd\/dmv016","article-title":"Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century","volume":"21","author":"Inhorn","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"23","key":"10.1016\/j.bpobgyn.2023.102340_bib4","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.18632\/aging.102497","article-title":"Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from a global burden of disease study, 2017","volume":"11","author":"Sun","year":"2019","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102340_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib6","series-title":"Fertility problems: assessment and treatment: clinical guideline [CG156]","year":"2017"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib7","series-title":"Infertility: treatment","author":"National Health Service","year":"2020"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102340_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.2047-2927.2013.00107.x","article-title":"Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis","volume":"1","author":"Chua","year":"2013","journal-title":"Andrology"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/jhrs.JHRS_9_17","article-title":"Tamoxifen is better than low-dose clomiphene or gonadotropins in women with thin endometrium (<7 mm) after clomiphene in intrauterine insemination cycles: a prospective study","volume":"11","author":"Sharma","year":"2018","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib10","series-title":"American Society for Reproductive Medicine: Side effects of injectable fertility Drugs (gonadotropins)","year":"2012"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-10-26","article-title":"GnRH agonist versus GnRH antagonist in in\u00a0vitro fertilization and embryo transfer (IVF\/ET)","volume":"10","author":"Depalo","year":"2012","journal-title":"Reprod Biol Endocrinol : RB&E"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102340_bib12","first-page":"1","article-title":"Assisted reproductive technology surveillance - United States, 2017","volume":"69","author":"Sunderam","year":"2020","journal-title":"Morb Mortal Wkly Rep - Surveillance Summ"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib13","series-title":"Assisted reproductive technology (ART): ART success rates","year":"2019"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102340_bib14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/humrep\/del075","article-title":"Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE","volume":"21","author":"Andersen","year":"2006","journal-title":"Hum Reprod (Oxf)"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102340_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa032","article-title":"ART in Europe, 2018: results generated from European registries by ESHRE","volume":"2022","author":"Wyns","year":"2022","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib16","series-title":"IVF: chances of success","year":"2021"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib17","series-title":"Encyclopedia of environmental health","first-page":"871","article-title":"General introduction to valuation of human health risks","author":"Markandya","year":"2011"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102340_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11211-018-0322-9","article-title":"Explicit cost-effectiveness thresholds in health care: a kaleidoscope","volume":"32","author":"Luyten","year":"2019","journal-title":"Soc Justice Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"Hutubessy","year":"2003","journal-title":"Cost Eff Resour Allocation"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102340_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102340_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajo.12988","article-title":"A\u00a0cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age","volume":"59","author":"Lee","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2023.102340_bib22","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/humrep\/dev163","article-title":"Economic aspects of infertility care: a challenge for researchers and clinicians","volume":"30","year":"2015","journal-title":"Hum Reprod (Oxf)"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bpobgyn.2022.01.008","article-title":"Economic evaluation of Medically Assisted Reproduction: an educational overview of methods and applications for healthcare professionals","volume":"85","author":"Luyten","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102340_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib26","doi-asserted-by":"crossref","DOI":"10.2196\/13355","article-title":"Web comparison of three contingent valuation techniques in women of childbearing age: the case of ovulation induction in Quebec","volume":"9","author":"Dieng","year":"2020","journal-title":"Interact J Med Res"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/cer.15.51","article-title":"Social and private benefits of assisted reproductive technology: a national survey-based evaluation in Israel","volume":"5","author":"Gonen","year":"2016","journal-title":"Journal of comparative effectiveness research"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102340_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/cer-2016-0066","article-title":"Donor insemination: Israel as a representative case of a competitive market examining the possibility of policy reform","volume":"6","author":"Gonen","year":"2017","journal-title":"Journal of comparative effectiveness research"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejogrb.2021.01.026","article-title":"A\u00a0questionnaire survey on patients' willingness to pay with reference to the waiting time of public in-vitro fertilization treatment in Hong Kong","volume":"258","author":"Lai","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102340_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00005650-199407000-00003","article-title":"The willingness to pay for in\u00a0vitro fertilization: a pilot study using contingent valuation","volume":"32","author":"Neumann","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib31","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/PPA.S67742","article-title":"Willingness to pay for ovulation induction treatment in case of WHO II anovulation: a study using the contingent valuation method","volume":"8","author":"Poder","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102340_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1099-1050(199611)5:6<543::AID-HEC230>3.0.CO;2-R","article-title":"Using willingness to pay to assess the benefits of assisted reproductive techniques","volume":"5","author":"Ryan","year":"1996","journal-title":"Health Econ"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102340_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/000368497326499","article-title":"Should government fund assisted reproductive techniques? A study using willingness to pay","volume":"29","author":"Ryan","year":"1997","journal-title":"Appl Econ"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-4870(98)00003-8","article-title":"Valuing psychological factors in the provision of assisted reproductive techniques using the economic instrument of willingness to pay","volume":"19","author":"Ryan","year":"1998","journal-title":"J\u00a0Econ Psychol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102340_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hec.818","article-title":"A\u00a0comparison of stated preference methods for estimating monetary values","volume":"13","author":"Ryan","year":"2004","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40258-018-0433-3","article-title":"Reliability and validity of the contingent valuation method for estimating willingness to pay: a case of in\u00a0vitro fertilisation","volume":"17","author":"Settumba","year":"2019","journal-title":"Appl Health Econ Health Pol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102340_bib37","first-page":"535","article-title":"Economic implications of in\u00a0vitro fertilization using willingness to pay","volume":"21","author":"Spiegel","year":"2013","journal-title":"J\u00a0Public Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tjog.2020.11.019","article-title":"Cost-effectiveness of freeze-all policy \u2013 a retrospective study based upon the outcome of cumulative live births","volume":"60","author":"Chang","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102340_bib39","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1016\/j.fertnstert.2020.08.1202","article-title":"Financial decision analysis for surgical sperm retrieval approaches","volume":"114","author":"Han","year":"2020","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102340_bib40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2006.11.199","article-title":"Markov modeling of vasectomy reversal and ART for infertility: how do obstructive interval and female partner age influence cost effectiveness?","volume":"88","author":"Hsieh","year":"2007","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.bpobgyn.2023.102340_bib41","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/humrep\/dey253","article-title":"A\u00a0cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women","volume":"33","author":"Le","year":"2018","journal-title":"Hum Reprod (Oxf)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12958-018-0386-2","article-title":"Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF","volume":"16","author":"Mennini","year":"2018","journal-title":"Reprod Biol Endocrinol: RB&E"},{"issue":"11","key":"10.1016\/j.bpobgyn.2023.102340_bib43","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/humrep\/deab207","article-title":"Assessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment","volume":"36","author":"Abdulrahim","year":"2021","journal-title":"Hum Reprod (Oxf)"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102340_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40271-021-00563-7","article-title":"How do people with experience of infertility value different aspects of assistive reproductive therapy? Results from a multi-country discrete choice experiment","volume":"15","author":"Skedgel","year":"2022","journal-title":"Patient"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vhri.2020.03.003","article-title":"Willingness of infertile couples to pay for in\u00a0vitro fertilization treatment in the integrated human reproduction section of the escola paulista de Medicina","volume":"23","author":"Lima","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102340_bib46","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/der139","article-title":"Willingness to pay and conjoint analysis to determine women's preferences for ovarian stimulating hormones in the treatment of infertility in Spain","volume":"26","author":"Palumbo","year":"2011","journal-title":"Hum Reprod (Oxf)"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102340_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00016349509008938","article-title":"Couples' willingness to pay for IVF\/ET","volume":"74","author":"Granberg","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102340_bib48","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1021\/es990728j","article-title":"Contingent valuation: a user's guide","volume":"34","author":"Carson","year":"2000","journal-title":"Environ Sci Technol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7827-7-101","article-title":"Biological versus chronological ovarian age: implications for assisted reproductive technology","volume":"7","author":"Alviggi","year":"2009","journal-title":"Reprod Biol Endocrinol: RB&E"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib50","article-title":"What features of fertility treatment do patients value? Price elasticity and willingness-to-pay values from a discrete choice experiment","author":"Keller","year":"2022","journal-title":"Appl Health Econ Health Pol"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib51","series-title":"Making choices in health: WHO guide to cost effectiveness analysis Geneva","year":"2003"},{"issue":"Pt B","key":"10.1016\/j.bpobgyn.2023.102340_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bpobgyn.2022.02.002","article-title":"Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry","volume":"85","author":"Buhler","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Pt B","key":"10.1016\/j.bpobgyn.2023.102340_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bpobgyn.2022.01.011","article-title":"Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: a cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers","volume":"85","author":"Schwarze","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102340_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231584","article-title":"Cost-benefit Analysis of IUI and IVF based on willingness to pay approach; case study: Iran","volume":"15","author":"Darvishi","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102340_bib55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hec.4454","article-title":"To be or not to be: future lives in economic evaluation","volume":"31","author":"Luyten","year":"2022","journal-title":"Health Econ"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102340_bib56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","article-title":"Adjusting for inflation and currency changes within health economic studies","volume":"22","author":"Turner","year":"2019","journal-title":"Value Health: J Int Soc PharmacoEcon Outcomes Res"},{"key":"10.1016\/j.bpobgyn.2023.102340_bib57","series-title":"Report of the NOAA panel on contingent valuation","author":"Arrow","year":"1993"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:14:18Z","timestamp":1761498858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693423000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":56,"alternative-id":["S1521693423000408"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102340","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of treatment for infertility: A systematic literature review of willingness-to-pay thresholds and approaches for determining the cost effectiveness of fertility therapies","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102340"}}